HIGHLIGHTS
- who: Giuseppe Lapadula from the Shandong University, China have published the research work: Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19, in the Journal: (JOURNAL)
- what: The study has some limitations that should be acknowledged.
SUMMARY
Plasma levels of PTX3 have been reported to predict mortality in several systemic inflammatory conditions, including acute myocardial infarction and sepsis. In a cohort of 96 patients with COVID-19, PTX3 levels measured at hospital admission were significantly increased compared to healthy controls and were predictors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.